1 / 36

Iron Overload in Chronic Anaemias

Iron Overload in Chronic Anaemias. Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory. Preview. Why we need iron The iron economy Why too much iron is a bad thing Pumping (out) iron Current recommendations for treatment of iron overload in MDS.

lindayoung
Download Presentation

Iron Overload in Chronic Anaemias

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory

  2. Preview • Why we need iron • The iron economy • Why too much iron is a bad thing • Pumping (out) iron • Current recommendations for treatment of iron overload in MDS

  3. Why we need iron • Enzymes • Oxygen transport • Haemoglobin (red blood cells) • Myoglobin (muscle cells) • About 70% of the body’s iron is in these proteins

  4. The iron economy

  5. The iron economy is well-balanced. 70% 30%

  6. We cope well with iron shortage… • Iron deficiency is the most common deficiency state in the world • Blood loss • dietary • About 1000 mg of iron is stored as ferritin (1/3 of total body iron) • Intestinal absorption of iron increases in response to deficiency

  7. …but poorly with iron excess. • Iron is excreted by shedding of intestinal cells • There is no physiologic mechanism to excrete excessive iron

  8. Normal daily iron flux: 1-2 mg Each unit of PRBC: Blood transfusion overwhelms the iron balance 200-250 mg

  9. Summary: Iron is in a fine balance • In normal circumstances, not much iron enters or leaves the body • The body cannot increase its excretion of iron. • Blood transfusions contain much iron, so patients who need frequent transfusions will build up excess iron.

  10. Why too much iron is a bad thing

  11. Free Iron Reticuloendothelial System Dying RBC Liver Endocrine organs CIRRHOSIS Heart DIABETES ARRHYTHMIA HEART FAILURE

  12. Lessons from thalassaemia

  13. When does iron become a problem? • Normally 2.5 – 3 grams of iron in the body. • Tissue damage when total body iron is 7 – 15 grams • After 30-50 units of red blood cells

  14. How do we know if there’s too much iron? • Serum ferritin concentration • Used in clinical practice globally • Liver biopsy • Reference methodology (‘gold standard’) • Magnetic resonance imaging (MRI) • Investigational, potential for broad access • Magnetic susceptometry (SQUID) • Investigational, very limited access

  15. Serum Ferritin Concentration • Easy • Inexpensive • Can be tricky – not purely iron • Inflammation (acute phase reactant) • Liver function abnormalities • Not perfect marker in iron overload • What it lacks in accuracy it makes up for in part with world-wide availability

  16. 300 r = 0.98 250 200 150 Total body iron stores, mg/kg 100 50 0 0 5 10 15 20 25 Hepatic iron concentration, mg/g dry weight Liver Biopsy 25 patients with iron overload andcirrhosis  1 mg dry weight liver sample • LIC accurately reflects total body iron stores LIC = Liver iron concentration. Reprinted with permission from Angelucci E, et al. N Engl J Med. 2000;343:327-331.

  17. Magnetic Susceptometry (SQUID) • Superconducting QUantum Interference Device • High-power magnetic field • Iron interferes with the field • Changes in the field are detected • Noninvasive, sensitive, and accurate • Limited availability • Superconductor requires high maintenance • Only 4 machines worldwide Photograph courtesy of A. Piga

  18. Magnetic Resonance Imaging Bright = high iron concentration; dark areas = low iron concentration

  19. Summary: Too much iron is bad • Iron overload caused by transfusions causes malfunction of the liver, heart, and endocrine organs. • Problems may begin after 30 units of RBC (or even earlier) • We use serum ferritin level to estimate iron levels • MRI might be better

  20. Iron chelation Out

  21. Metal Metal What is Chelation Therapy? Toxic Non-Toxic Chelator Chelator OutsidetheBody + “Chelate”

  22. How to chelate? • Currently licensed in Canada: • Deferoxamine • Alternatives • Deferiprone (L1) • Available on compassionate release • Deferasirox (ICL670, Exjade) • Undergoing accelerated review by Health Canada

  23. Deferoxamine: Mode of Action

  24. Challenges of Deferoxamine • Subcutaneous/Intravenous route of administration • Expensive • Cumbersome • Uncomfortable • Rapid metabolism (30 minute half-life) necessitates prolonged infusion (12-15 hours) • Complications due to iron overload still occur due to poor compliance with therapy

  25. Deferoxamine infusion

  26. Common Side Effects of Deferoxamine • Local reactions • Erythema (localized redness) • Induration (localized swelling) • Pruritus (itchiness) • Ophthalmologic • Reduced visual acuity • Impaired color vision • Night blindness • Increased by presence of diabetes • Hearing loss • Zinc deficiency

  27. Are we certain it helps? Survival of patients with thalassaemia

  28. Summary: Iron chelation and deferoxamine • Chelation works by attaching a drug to iron, which allows the body to excrete it. • Deferoxamine is awful stuff… • Inconvenient and uncomfortable to take • Many nasty side effects • …but it works • Enormous extension of lifespan in thalassaemia.

  29. ICL670: Deferasirox, Exjade • Oral, dispersible tablet • Taken once daily • Highly specific for iron • Chelated iron excreted mainly in faeces • Less than 10% excreted in the urine

  30. ICL670 works. Deferoxamine 0107 ICL670 0107 ICL670 0108 g/L Deferoxamine < 25 25-35 35-50 ≥ 50 ICL670 5 10 20 30 All doses in mg/kg/day

  31. ICL670 is Generally Tolerable • The most common adverse events were mild and transient: • Nausea (10%) • Vomiting (9%) • Abdominal pain (14%) • Diarrhea (12%) • Skin rash (8%) • Rarely required discontinuation of study drug • Mild increases in serum creatinine • No agranulocytosis observed

  32. When can we have Exjade? • Already FDA-approved in the USA • Health Canada approval expected September 2006 • Provincial formularies will need to decide whether to include Exjade.

  33. What do the experts say?

  34. Recommended Treatment for Iron Overload in MDS • Why: to prevent end-organ complications of iron overload and extend lifespan • Whom: transfusion-dependent patients with expected survival > 1 year • When: after 25 units RBC transfused, ferritin >1000. • How: Desferal by subcutaneous infusion (for now); keep ferritin<1000

  35. Summary • Iron overload is an inevitable consequence of chronic RBC transfusion • Iron toxicity affects the function of the liver, heart, and endocrine organs • Chelation therapy should be offered to iron overloaded patients with life expectancy >1 year • Desferal is the only drug currently available; Exjade will be available soon.

  36. Thank you!

More Related